Van den Brande et al., 1974 - Google Patents

Primary somatomedin deficiency: case report

Van den Brande et al., 1974

View PDF
Document ID
10565501371314661300
Author
Van den Brande J
Du Caju M
Visser H
Schopman W
Hackeng W
Degenhart H
Publication year
Publication venue
Archives of Disease in Childhood

External Links

Snippet

A child presenting with the clinical features of hyposomatotropism but with high immunoreactive plasma growth hormone is described. During short-term administration of human growth hormone (HGH) his response with regard to fasting blood-glucose and free …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones

Similar Documents

Publication Publication Date Title
Barbul et al. Wound healing and thymotropic effects of arginine: a pituitary mechanism of action
Guyda et al. Serum prolactin levels in humans from birth to adult life
Wren et al. Ghrelin enhances appetite and increases food intake in humans
SORVA Children with craniopharyngioma: early growth failure and rapid postoperative weight gain
Hirschberg et al. The delayed effect of growth hormone on renal function in humans
Grumbach et al. Plasma free fatty acid response to the administration of chorionic “growth hormone-prolactin”
Van den Brande et al. Primary somatomedin deficiency: case report
Ghavami-Maibodi et al. Effect of oral zinc supplements on growth, hormonal levels, and zinc in healthy short children
De Zegher et al. Hypersomatotropism in the dysmature infant at term and preterm birth
Moncrieff et al. Congenital absence of pituitary gland and adrenal hypoplasia.
Mimouni et al. Hypertension in a neonate with 11 β-hydroxylase deficiency
Martinez et al. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol
KAPLOWITZ et al. Peripheral resistance to thyroid hormone in an infant
Sinha et al. Effect on growth of prolactin deficiency induced in infant mice
Seip et al. Experiences with human growth hormone in pituitary dwarfism
AU2002321557B2 (en) Use of leptin for infant with low birth weight for prevention of obesity
Ingenbleek et al. Thyroxine-binding globulin in infant protein-calorie malnutrition
Ritzén et al. Endocrine physiology and therapy in Prader-Willi syndrome
AU2002321557A1 (en) Use of leptin for infant with low birth weight for prevention of obesity
JP2573976B2 (en) Use of growth hormone for nitrogen retention in low calorie conditions
HACKENG et al. Primary somatomedin deficiency
JP3074302B2 (en) Compositions for treating human lactation deficiency
PAINE et al. The dietary phenylalanine requirements and tolerances of phenylketonuric patients
Häger et al. Studies on growth hormone secretion in a patient with the diencephalic syndrome of emaciation
Ashton et al. Plasma somatomedin activity in an infant with Beckwith—Wiedemann syndrome